Über uns
Dr Anna Kirby is a Consultant Clinical Oncologist specialising in the treatment of patients with breast cancer. She leads research into novel breast radiotherapy techniques at the Royal Marsden and Institute of Cancer Research. She is Chief Investigator of the UK HeartSpare study, and breast lead investigator on the CORE trial evaluating the role of stereotactic radiotherapy in treating metastatic disease.
Dr Kirby graduated from Cambridge University in 1995 with a first-class honours degree in Medicine and Psychology. Her specialist oncology training was completed at The Royal Marsden and Guy's and St Thomas' Hospitals following which she undertook a research degree at the Institute of Cancer Research. Her publications describe methods for improving the accuracy of breast cancer radiotherapy and for reducing late side-effects of treatment including heart disease. Her work in heart-sparing breast radiotherapy has changed national practice. Her current research interests include combining breath-hold and volumetric-modulated arc therapy to minimise heart and lung doses in women with lymph-node positive breast cancer, reversing the order of breast cancer treatments to reduce the impact of radiotherapy on breast reconstructions, and investigating the applications of MR-linac technology to the treatment of breast cancer.
She is also a keen singer, cook and tennis player.
Diseases, Medical Tests and TreatmentsHeart-Sparing Breast Radiotherapy
Stereotactic Radiotherapy
Breast Radiotherapy
Dr Kirby graduated from Cambridge University in 1995 with a first-class honours degree in Medicine and Psychology. Her specialist oncology training was completed at The Royal Marsden and Guy's and St Thomas' Hospitals following which she undertook a research degree at the Institute of Cancer Research. Her publications describe methods for improving the accuracy of breast cancer radiotherapy and for reducing late side-effects of treatment including heart disease. Her work in heart-sparing breast radiotherapy has changed national practice. Her current research interests include combining breath-hold and volumetric-modulated arc therapy to minimise heart and lung doses in women with lymph-node positive breast cancer, reversing the order of breast cancer treatments to reduce the impact of radiotherapy on breast reconstructions, and investigating the applications of MR-linac technology to the treatment of breast cancer.
She is also a keen singer, cook and tennis player.
Diseases, Medical Tests and TreatmentsHeart-Sparing Breast Radiotherapy
Stereotactic Radiotherapy
Breast Radiotherapy
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Anna Kirby
Ausbildung & Training
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Onkologie
-
2012–2013 Fellowship · Subspecialty training
Karriere & Anstellungen
-
2012-09–2013-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
GB — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
HDI Global · 2,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 1,074 |
| Annual physical exam | 99395 | 2,156 |
| Vaccination administration | 90471 | 1,204 |
| Minor procedure (skin) | 17110 | 59 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 Min. | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 60 Min. | in_clinic | 720.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 7 · i10: 9
-
Outcomes of Onkologie in adults — a multi-centre cohort
DOI: 10.3196/euroclin.2025.0 · PMID: 32939095 · zitiert von 50
-
European registry analysis of Onkologie outcomes
DOI: 10.2347/euroclin.2024.1 · PMID: 38670949 · zitiert von 104
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · London · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — London · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2013
- national college of family doctors — Member · Seit 2013
- European Union of Medical Specialists (UEMS) — Member · Seit 2013
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · dr.anna.kirby@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Ähnliche Spezialisten
Alle durchsuchen →
Mr Abdulla Alhasso
Onkologie · Glasgow
Dr Alexander McDonald
Onkologie · Glasgow
Dr Amna Sheri
Onkologie · London
Dr Angus Robinson
Onkologie · Horley
Dr Anne Armstrong
Onkologie · Manchester
Dr Ashraf Azzabi
Onkologie · Washington
Dr Clare Green
Onkologie · Winchester
Dr Desmond Yip
Onkologie · Garran